| Market Cap | 4.55B 3.91B 3.68B 3.36B 6.27B 431B 6.3B 43.61B 16.87B 220B 17.09B 16.71B 702B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.04B 3.8B 3.47B 6.47B 445B 6.51B 45.03B 17.42B 228B 17.64B 17.26B 725B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Amicus Therapeutics
| 1 day | +1.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | +1.65% | - | - | 4.55B | |
| -2.14% | -7.16% | -4.71% | +11.17% | 48.01B | |
| +1.18% | -1.81% | +401.80% | +525.00% | 44.44B | |
| -1.27% | -3.01% | +34.95% | +18.85% | 42.67B | |
| -0.18% | -4.10% | -1.19% | +65.82% | 39.96B | |
| -1.72% | -2.61% | +13.09% | +42.33% | 32.75B | |
| -0.40% | +0.83% | - | - | 17.74B | |
| -0.93% | -1.05% | +20.85% | +110.07% | 16.49B | |
| +0.20% | -1.98% | +11.54% | +31.67% | 14.38B | |
| -0.01% | -4.26% | +77.49% | +39.90% | 13.4B | |
| Average | -0.39% | -0.48% | +69.23% | +105.60% | 29.98B | |
| Weighted average by Cap. | -0.66% | -1.05% | +83.49% | +124.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 454M 427M 390M 728M 50.08B 732M 5.06B 1.96B 25.6B 1.98B 1.94B 81.46B | 634M 545M 513M 468M 874M 60.13B 878M 6.08B 2.35B 30.73B 2.38B 2.33B 97.8B |
| Net income | -56.11M -48.24M -45.38M -41.42M -77.29M -5.32B -77.69M -538M -208M -2.72B -211M -206M -8.65B | -27.11M -23.31M -21.93M -20.01M -37.35M -2.57B -37.54M -260M -101M -1.31B -102M -99.58M -4.18B |
| Net Debt | 194M 167M 157M 143M 267M 18.36B 268M 1.86B 718M 9.39B 727M 711M 29.87B | 149M 128M 120M 110M 205M 14.11B 206M 1.43B 552M 7.21B 559M 547M 22.95B |
Employees
-
